Company intelligence / Profile preview

FutureScape

San Francisco, California, United States

Ownership: Private
Employees: ~18
Development stage: Other

Overview

FutureScape (operating as Wonderfeel) is a San Francisco-based life sciences company dedicated to advancing longevity and cellular health through bioscience-backed solutions. The company's flagship product, Wonderfeel Youngr NMN, is a high-dose nicotinamide mononucleotide (NMN) supplement developed in collaboration with leading scientists to boost NAD+ levels and promote healthy aging. FutureScape combines rigorous clinical research with consumer-centric design to deliver products that optimize human healthspan. Led by a team of experienced entrepreneurs and medical experts, including renowned drug developer Dr. Andrew Salzman, the company aims to make cutting-edge longevity science accessible to a broad audience.

Therapeutic areas: ImmunologyNeurologyOther
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on FutureScape.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FutureScape.

Explore the full profile